Skip to Content

Tong Ren Tang Technologies Co Ltd Class H TGRNF

Morningstar Rating
$0.86 +0.01 (1.47%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TGRNF is trading within a range we consider fairly valued.
Price
$0.86
Fair Value
$2.87
Uncertainty
Very High
1-Star Price
$6.97
5-Star Price
$5.39
Economic Moat
Qwmf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TGRNF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.85
Day Range
$0.860.86
52-Week Range
$0.690.86
Bid/Ask
$0.67 / $0.74
Market Cap
$1.10 Bil
Volume/Avg
5,952 / 42,276

Key Statistics

Price/Earnings (Normalized)
11.99
Price/Sales
1.11
Dividend Yield (Trailing)
2.61%
Dividend Yield (Forward)
0.33%
Total Yield
2.61%

Company Profile

Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and primarily operates in Mainland China and Hong Kong. The operating segments derive their revenue primarily from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Mid Value
Total Number of Employees
4,030

Comparables

Valuation

Metric
TGRNF
03613
601607
Price/Earnings (Normalized)
11.9911.0018.63
Price/Book Value
1.202.130.95
Price/Sales
1.113.990.26
Price/Cash Flow
7.3710.909.19
Price/Earnings
TGRNF
03613
601607

Financial Strength

Metric
TGRNF
03613
601607
Quick Ratio
2.9610.411.00
Current Ratio
4.4912.531.34
Interest Coverage
25.85174.384.82
Quick Ratio
TGRNF
03613
601607

Profitability

Metric
TGRNF
03613
601607
Return on Assets (Normalized)
8.59%18.53%1.90%
Return on Equity (Normalized)
16.87%21.30%5.78%
Return on Invested Capital (Normalized)
10.17%18.96%4.15%
Return on Assets
TGRNF
03613
601607
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
LLY
Eli Lilly and CoNqhc$731.2 Bil
JNJ
Johnson & JohnsonRdb$389.8 Bil
MRK
Merck & Co IncKwj$328.0 Bil
ABBV
AbbVie IncVpbz$314.6 Bil
NVS
Novartis AG ADRDtk$212.8 Bil
RHHBY
Roche Holding AG ADRZcyj$212.4 Bil
AZN
AstraZeneca PLC ADRSynp$200.6 Bil
PFE
Pfizer IncNnf$156.7 Bil
AMGN
Amgen IncBlwb$155.0 Bil
SNY
Sanofi SA ADRQwzz$121.2 Bil

Sponsor Center